{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:01:41Z","timestamp":1790514101969,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10753-019-00973-8","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T02:18:20Z","timestamp":1549851500000},"page":"1103-1116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Umbelliferone Ameliorates CCl4-Induced Liver Fibrosis in Rats by Upregulating PPAR\u03b3 and Attenuating Oxidative Stress, Inflammation, and TGF-\u03b21\/Smad3 Signaling"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0279-6500","authenticated-orcid":false,"given":"Ayman M.","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa G.","family":"Hozayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman H.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Bin-Jumah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"973_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","volume":"36","author":"WR Kim","year":"2002","unstructured":"Kim, W.R., R.S. Brown Jr., N.A. Terrault, and H. El-Serag. 2002. Burden of liver disease in the United States: summary of a workshop. Hepatology (Baltimore, Md.) 36: 227\u2013242.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"973_CR2","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"CY Zhang","year":"2016","unstructured":"Zhang, C.Y., W.G. Yuan, P. He, J.H. Lei, and C.X. Wang. 2016. Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World Journal of Gastroenterology 22: 10512\u201310522.","journal-title":"World Journal of Gastroenterology"},{"key":"973_CR3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2015.03.039","volume":"63","author":"F Tacke","year":"2015","unstructured":"Tacke, F., and C. Trautwein. 2015. Mechanisms of liver fibrosis resolution. Journal of Hepatology 63: 1038\u20131039.","journal-title":"Journal of Hepatology"},{"key":"973_CR4","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/nbm.3431","volume":"28","author":"S Josan","year":"2015","unstructured":"Josan, S., K. Billingsley, J. Orduna, J.M. Park, R. Luong, L. Yu, R. Hurd, A. Pfefferbaum, D. Spielman, and D. Mayer. 2015. Assessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1-(13)C] pyruvate. NMR in Biomedicine 28: 1671\u20131677.","journal-title":"NMR in Biomedicine"},{"key":"973_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman, S.L. 2008. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiological Reviews 88: 125\u2013172.","journal-title":"Physiological Reviews"},{"key":"973_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cbi.2018.12.006","volume":"299","author":"Q Cheng","year":"2019","unstructured":"Cheng, Q., C. Li, C.-f. Yang, Y.-j. Zhong, D. Wu, L. Shi, L. Chen, Y.-w. Li, and L. Li. 2019. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-\u03b21\/Smad and NOX4\/ROS pathways. Chemico-Biological Interactions 299: 131\u2013139.","journal-title":"Chemico-Biological Interactions"},{"key":"973_CR7","first-page":"1","volume":"7","author":"CR Gandhi","year":"2012","unstructured":"Gandhi, C.R. 2012. Oxidative stress and hepatic stellate cells: a paradoxical relationship. Trends in Cell & Molecular Biology 7: 1\u201310.","journal-title":"Trends in Cell & Molecular Biology"},{"key":"973_CR8","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ajpath.2014.04.014","volume":"184","author":"WJ Duan","year":"2014","unstructured":"Duan, W.J., X. Yu, X.R. Huang, J.W. Yu, and H.Y. Lan. 2014. Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro. American Journal of Pathology 184: 2275\u20132284.","journal-title":"American Journal of Pathology"},{"key":"973_CR9","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/A812","volume":"7","author":"AM Gressner","year":"2002","unstructured":"Gressner, A.M., R. Weiskirchen, K. Breitkopf, and S. Dooley. 2002. Roles of TGF-beta in hepatic fibrosis. Frontiers in Bioscience : a Journal and Virtual Library 7: d793\u2013d807.","journal-title":"Frontiers in Bioscience : a Journal and Virtual Library"},{"key":"973_CR10","doi-asserted-by":"crossref","first-page":"37731","DOI":"10.1074\/jbc.R100034200","volume":"276","author":"ED Rosen","year":"2001","unstructured":"Rosen, E.D., and B.M. Spiegelman. 2001. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. The Journal of Biological Chemistry 276: 37731\u201337734.","journal-title":"The Journal of Biological Chemistry"},{"key":"973_CR11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jlb.66.5.733","volume":"66","author":"M Ricote","year":"1999","unstructured":"Ricote, M., J.T. Huang, J.S. Welch, and C.K. Glass. 1999. The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte\/macrophage function. Journal of Leukocyte Biology 66: 733\u2013739.","journal-title":"Journal of Leukocyte Biology"},{"issue":"8","key":"973_CR12","first-page":"793","volume":"30","author":"Y Yu","year":"2014","unstructured":"Yu, Y., Y. Wu, G. Wen, and W. Yang. 2014. Effect of pioglitazone on the expression of TLR4 in renal tissue of diabetic rats. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 30 (8): 793\u2013797.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"973_CR13","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.cellsig.2011.05.018","volume":"23","author":"LC Lin","year":"2011","unstructured":"Lin, L.C., S.L. Hsu, C.L. Wu, W.C. Liu, and C.M. Hsueh. 2011. Peroxisome proliferator-activated receptor gamma (PPARgamma) plays a critical role in the development of TGFbeta resistance of H460 cell. Cellular Signalling 23: 1640\u20131650.","journal-title":"Cellular Signalling"},{"key":"973_CR14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cbi.2017.09.015","volume":"277","author":"AM Mahmoud","year":"2017","unstructured":"Mahmoud, A.M., H.M. Mohammed, S.M. Khadrawy, and S.R. Galaly. 2017. Hesperidin protects against chemically induced hepatocarcinogenesis via modulation of Nrf2\/ARE\/HO-1, PPARgamma and TGF-beta1\/Smad3 signaling, and amelioration of oxidative stress and inflammation. Chemico-Biological Interactions 277: 146\u2013158.","journal-title":"Chemico-Biological Interactions"},{"key":"973_CR15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1139\/cjpp-2014-0204","volume":"92","author":"AM Mahmoud","year":"2014","unstructured":"Mahmoud, A.M. 2014. Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPAR\u03b3 and abrogation of oxidative stress and inflammation. Canadian Journal of Physiology and Pharmacology 92: 717\u2013724.","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"973_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12263-015-0491-1","volume":"10","author":"AM Mahmoud","year":"2015","unstructured":"Mahmoud, A.M., and H.S. Al Dera. 2015. 18\u03b2-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPAR\u03b3 and Nrf2 upregulation. Genes & Nutrition 10: 1\u201313.","journal-title":"Genes & Nutrition"},{"key":"973_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biopha.2016.12.047","volume":"86","author":"AM Mahmoud","year":"2017","unstructured":"Mahmoud, A.M., M.O. Germoush, M.F. Alotaibi, and O.E. Hussein. 2017. Possible involvement of Nrf2 and PPARgamma up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity. Biomedicine & Pharmacotherapy 86: 297\u2013306.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"973_CR18","doi-asserted-by":"crossref","first-page":"4016209","DOI":"10.1155\/2016\/4016209","volume":"2016","author":"S Alqahtani","year":"2016","unstructured":"Alqahtani, S., and A.M. Mahmoud. 2016. Gamma-glutamylcysteine ethyl ester protects against cyclophosphamide-induced liver injury and hematologic alterations via upregulation of PPARgamma and attenuation of oxidative stress, inflammation, and apoptosis. Oxidative Medicine and Cellular Longevity 2016: 4016209.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"973_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2017.04.009","volume":"270","author":"AM Mahmoud","year":"2017","unstructured":"Mahmoud, A.M., O.E. Hussein, W.G. Hozayen, and S.M. Abd El-Twab. 2017. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARgamma and Nrf2: protective effect of 18beta-glycyrrhetinic acid. Chemico-Biological Interactions 270: 59\u201372.","journal-title":"Chemico-Biological Interactions"},{"key":"973_CR20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.biopha.2017.07.101","volume":"94","author":"AM Mahmoud","year":"2017","unstructured":"Mahmoud, A.M., W.G. Hozayen, and S.M. Ramadan. 2017. Berberine ameliorates methotrexate-induced liver injury by activating Nrf2\/HO-1 pathway and PPARgamma, and suppressing oxidative stress and apoptosis in rats. Biomedicine & Pharmacotherapy 94: 280\u2013291.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"973_CR21","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.3109\/13880209.2016.1160938","volume":"54","author":"E Abdella","year":"2016","unstructured":"Abdella, E., A. Mahmoud, and A. El-Derby. 2016. Brown seaweeds protect against azoxymethane-induced hepatic repercussions through up-regulation of peroxisome proliferator activated receptor gamma and attenuation of oxidative stress. Pharmaceutical Biology 54: 2496\u20132504.","journal-title":"Pharmaceutical Biology"},{"key":"973_CR22","doi-asserted-by":"crossref","first-page":"G902","DOI":"10.1152\/ajpgi.00124.2006","volume":"291","author":"L Yang","year":"2006","unstructured":"Yang, L., C.-C. Chan, O.-S. Kwon, S. Liu, J. McGhee, S.A. Stimpson, L.Z. Chen, W.W. Harrington, W.T. Symonds, and D.C. Rockey. 2006. Regulation of peroxisome proliferator-activated receptor-\u03b3 in liver fibrosis. American Journal of Physiology - Gastrointestinal and Liver Physiology 291: G902\u2013G911.","journal-title":"American Journal of Physiology - Gastrointestinal and Liver Physiology"},{"key":"973_CR23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00011-010-0226-0","volume":"59","author":"L Yang","year":"2010","unstructured":"Yang, L., S.A. Stimpson, L. Chen, W.W. Harrington, and D.C. Rockey. 2010. Effectiveness of the PPAR\u03b3 agonist, GW570, in liver fibrosis. Inflammation Research 59: 1061\u20131071.","journal-title":"Inflammation Research"},{"key":"973_CR24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bfopcu.2017.05.001","volume":"55","author":"O Mazimba","year":"2017","unstructured":"Mazimba, O. 2017. Umbelliferone: sources, chemistry and bioactivities review. Bulletin of Faculty of Pharmacy, Cairo University 55: 223\u2013232.","journal-title":"Bulletin of Faculty of Pharmacy, Cairo University"},{"key":"973_CR25","first-page":"189","volume":"78","author":"B Ramesh","year":"2005","unstructured":"Ramesh, B., and K.V. Pugalendi. 2005. Antihyperlipidemic and antidiabetic effects of umbelliferone in streptozotocin diabetic rats. The Yale Journal of Biology and Medicine 78: 189\u2013196.","journal-title":"The Yale Journal of Biology and Medicine"},{"key":"973_CR26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopha.2018.03.104","volume":"102","author":"MO Germoush","year":"2018","unstructured":"Germoush, M.O., S.I. Othman, M.A. Al-Qaraawi, H.M. Al-Harbi, O.E. Hussein, G. Al-Basher, M.F. Alotaibi, H.A. Elgebaly, M.A. Sandhu, A.A. Allam, and A.M. Mahmoud. 2018. Umbelliferone prevents oxidative stress, inflammation and hematological alterations, and modulates glutamate-nitric oxide-cGMP signaling in hyperammonemic rats. Biomedicine & Pharmacotherapy 102: 392\u2013402.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"973_CR27","doi-asserted-by":"crossref","first-page":"BSR20180444","DOI":"10.1042\/BSR20180444","volume":"38","author":"J Yin","year":"2018","unstructured":"Yin, J., H. Wang, and G. Lu. 2018. Umbelliferone alleviates hepatic injury in diabetic db\/db mice via inhibiting inflammatory response and activating Nrf2-mediated antioxidant. Bioscience Reports 38: BSR20180444.","journal-title":"Bioscience Reports"},{"key":"973_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1155\/2014\/245171","volume":"2014","author":"E Al-Sayed","year":"2014","unstructured":"Al-Sayed, E., O. Martiskainen, S.H. Seif el-Din, A.-N.A. Sabra, O.A. Hammam, N.M. El-Lakkany, and M.M. Abdel-Daim. 2014. Hepatoprotective and antioxidant effect of Bauhinia Hookeri extract against carbon tetrachloride-induced hepatotoxicity in mice and characterization of its bioactive compounds by HPLC-PDA-ESI-MS\/MS. BioMed Research International 2014: 9.","journal-title":"BioMed Research International"},{"key":"973_CR29","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.4103\/0973-1296.185765","volume":"12","author":"N Al-Rasheed","year":"2016","unstructured":"Al-Rasheed, N., L. Faddah, N. Al-Rasheed, Y.A. Bassiouni, I.H. Hasan, A.M. Mahmoud, R.A. Mohamad, and H.I. Yacoub. 2016. Protective effects of silymarin, alone or in combination with chlorogenic acid and\/or melatonin, against carbon tetrachloride-induced hepatotoxicity. Pharmacognosy Magazine 12: S337\u2013S345.","journal-title":"Pharmacognosy Magazine"},{"key":"973_CR30","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1055\/s-0034-1383211","volume":"80","author":"E Al-Sayed","year":"2014","unstructured":"Al-Sayed, E., and M.M. Abdel-Daim. 2014. Protective role of cupressuflavone from Cupressus macrocarpa against carbon tetrachloride-induced hepato- and nephrotoxicity in mice. Planta Medica 80: 1665\u20131671.","journal-title":"Planta Medica"},{"key":"973_CR31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/13880209.2015.1035794","volume":"54","author":"NM Fahmy","year":"2016","unstructured":"Fahmy, N.M., E. Al-Sayed, M.M. Abdel-Daim, M. Karonen, and A.N. Singab. 2016. Protective effect of Terminalia muelleri against carbon tetrachloride-induced hepato and nephro-toxicity in mice and characterization of its bioactive constituents. Pharmaceutical Biology 54: 303\u2013313.","journal-title":"Pharmaceutical Biology"},{"key":"973_CR32","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/s41598-017-06318-5","volume":"7","author":"X Li","year":"2017","unstructured":"Li, X., L. Wang, and C. Chen. 2017. Effects of exogenous thymosin \u03b24 on carbon tetrachloride-induced liver injury and fibrosis. Scientific Reports 7: 5872.","journal-title":"Scientific Reports"},{"key":"973_CR33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3727\/096368909788237140","volume":"18","author":"M Hardjo","year":"2009","unstructured":"Hardjo, M., M. Miyazaki, M. Sakaguchi, T. Masaka, S. Ibrahim, K. Kataoka, and N.H. Huh. 2009. Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. Cell Transplantation 18: 89\u201399.","journal-title":"Cell Transplantation"},{"key":"973_CR34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351\u2013358.","journal-title":"Analytical Biochemistry"},{"key":"973_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical Biochemistry 126: 131\u2013138.","journal-title":"Analytical Biochemistry"},{"key":"973_CR36","first-page":"882","volume":"61","author":"E Beutler","year":"1963","unstructured":"Beutler, E., O. Duron, and B.M. Kelly. 1963. Improved method for the determination of blood glutathione. The Journal of Laboratory and Clinical Medicine 61: 882\u2013888.","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"key":"973_CR37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund, S., and G. Marklund. 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase, FEBS. European Journal of Biochemistry 47: 469\u2013474.","journal-title":"European Journal of Biochemistry"},{"key":"973_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi, H. 1984. [13] Catalase in vitro. Methods in Enzymology 105: 121\u2013126.","journal-title":"Methods in Enzymology"},{"key":"973_CR39","first-page":"248","volume":"15","author":"B Matkovics","year":"1998","unstructured":"Matkovics, B., L. Szabo, and I.S. Varga. 1998. Determination of enzyme activities in lipid peroxidation and glutathione pathways (in Hungarian). Laboratoriumi Diagnosztika 15: 248\u2013249.","journal-title":"Laboratoriumi Diagnosztika"},{"issue":"4","key":"973_CR40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212delta delta c(t)) method. Methods 25 (4): 402\u2013408.","journal-title":"Methods"},{"issue":"Suppl 1","key":"973_CR41","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.clinre.2015.05.005","volume":"39","author":"D Schuppan","year":"2015","unstructured":"Schuppan, D. 2015. Liver fibrosis: common mechanisms and antifibrotic therapies. Clinics and Research in Hepatology and Gastroenterology 39 (Suppl 1): S51\u2013S59.","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"973_CR42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbrc.2011.05.023","volume":"409","author":"Q Lang","year":"2011","unstructured":"Lang, Q., Q. Liu, N. Xu, K.L. Qian, J.H. Qi, Y.C. Sun, L. Xiao, and X.F. Shi. 2011. The antifibrotic effects of TGF-\u03b21 siRNA on hepatic fibrosis in rats. Biochemical and Biophysical Research Communications 409: 448\u2013453.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"973_CR43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.fct.2018.07.048","volume":"120","author":"J Sun","year":"2018","unstructured":"Sun, J., Y. Wu, C. Long, P. He, J. Gu, L. Yang, Y. Liang, and Y. Wang. 2018. Anthocyanins isolated from blueberry ameliorates CCl4 induced liver fibrosis by modulation of oxidative stress, inflammation and stellate cell activation in mice. Food and Chemical Toxicology 120: 491\u2013499.","journal-title":"Food and Chemical Toxicology"},{"key":"973_CR44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/713611034","volume":"33","author":"LW Weber","year":"2003","unstructured":"Weber, L.W., M. Boll, and A. Stampfl. 2003. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Critical Reviews in Toxicology 33: 105\u2013136.","journal-title":"Critical Reviews in Toxicology"},{"key":"973_CR45","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.20235","volume":"39","author":"AJ Czaja","year":"2004","unstructured":"Czaja, A.J., and H.A. Carpenter. 2004. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology (Baltimore, Md.) 39: 1631\u20131638.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"973_CR46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1756283X11413002","volume":"4","author":"M Cohen-Naftaly","year":"2011","unstructured":"Cohen-Naftaly, M., and S.L. Friedman. 2011. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therapeutic Advances in Gastroenterology 4: 391\u2013417.","journal-title":"Therapeutic Advances in Gastroenterology"},{"key":"973_CR47","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0891-5849(01)00748-1","volume":"31","author":"MD Wheeler","year":"2001","unstructured":"Wheeler, M.D., H. Kono, M. Yin, M. Nakagami, T. Uesugi, G.E. Arteel, E. Gabele, I. Rusyn, S. Yamashina, M. Froh, Y. Adachi, Y. Iimuro, B.U. Bradford, O.M. Smutney, H.D. Connor, R.P. Mason, S.M. Goyert, J.M. Peters, F.J. Gonzalez, R.J. Samulski, and R.G. Thurman. 2001. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radical Biology & Medicine 31: 1544\u20131549.","journal-title":"Free Radical Biology & Medicine"},{"key":"973_CR48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1155\/2017\/9237263","volume":"2017","author":"S Satta","year":"2017","unstructured":"Satta, S., A.M. Mahmoud, F.L. Wilkinson, M. Yvonne Alexander, and S.J. White. 2017. The role of Nrf2 in cardiovascular function and disease. Oxidative Medicine and Cellular Longevity 2017: 18.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"973_CR49","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1159\/000438567","volume":"37","author":"S Jia","year":"2015","unstructured":"Jia, S., X. Liu, W. Li, J. Xie, L. Yang, and L. Li. 2015. Peroxisome proliferator-activated receptor gamma negatively regulates the differentiation of bone marrow-derived mesenchymal stem cells toward myofibroblasts in liver fibrogenesis. Cellular Physiology and Biochemistry 37: 2085\u20132100.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"973_CR50","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2353\/ajpath.2009.080574","volume":"174","author":"M Wu","year":"2009","unstructured":"Wu, M., D.S. Melichian, E. Chang, M. Warner-Blankenship, A.K. Ghosh, and J. Varga. 2009. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. The American Journal of Pathology 174: 519\u2013533.","journal-title":"The American Journal of Pathology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-019-00973-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-00973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-019-00973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T19:12:12Z","timestamp":1581361932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-019-00973-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1007\/s10753-019-00973-8","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"11 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental protocol and all animal procedures were approved by the Institutional Animal Ethics Committee of Beni-Suef University (Egypt).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}